Received Feb 3, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 2 | — | IM |
Reported Symptoms: 10084401:COVID-19 RESPIRATORY INFECTION; Narrative: Vaccinated patient (received both doses of Pfizer COVID vaccine 1/2021) was a resident of an assisted living facility that experienced a COVID-19 outbreak. He tested positive for COVID on 9/15/21, and noted increased oxygen requirements (2L at baseline up to 5L), along with cough (no fever or other symptoms reported). Admitted to the medical facility and treated with dexamethasone 6mg daily. Repeated COVID testing on 9/21/21 also positive). Chest CT was consistent w/ COVID-19 pneumonia. He improved to baseline and was discharged back to the assisted living facility. Dates of admission 9/21-9/27/21. Other Relevant HX: Problem list includes hypertension, diabetes, dyspnea Other: COVID-19 infection
COVID positive test on 9/15/21 and 9/21/21.